Literature DB >> 1486305

Poor growth in school entrants as an index of organic disease: the Wessex growth study.

L D Voss1, J Mulligan, P R Betts, T J Wilkin.   

Abstract

OBJECTIVE: To establish whether poor height or height velocity, assessed during the year of school entry, might identify children with previously undiagnosed organic disease.
DESIGN: Observation of a total population and their case controls.
SETTING: Community base.
SUBJECTS: All 14,346 children in two health districts entering school during two consecutive years were screened for height by school nurses, and those whose height lay below the 3rd centile according to Tanner and Whitehouse standards (n = 180) were identified. After excluding 32 with known organic disease, five from ethnic minorities, and three who refused to take part, the remaining 140 short normal children were matched with 140 age and sex matched controls of average height (10th-90th centile) and their height velocities over 12 months measured. MAIN OUTCOME MEASURES: Height, height velocity, previously diagnosed organic disease, and organic disease diagnosed as a result of blood tests and specialist examination.
RESULTS: Twenty five of the 180 short children (14%) were already known to have chronic organic disease which could explain their poor growth. Blood tests and specialist examination revealed a further seven with organic disease, which was acquired rather than congenital in three, and a second cause of short stature in one with known organic disease. These eight conditions had been missed at the school entry medical examination. The shorter the child, the more likely an underlying organic disorder, with seven of the 12 children whose heights were more than 3 standard deviations below the mean having some organic disease. Height velocity measured over 12 months, however, did not distinguish short normal children from those with disease or from their matched controls.
CONCLUSIONS: Height, but not height velocity, is a useful index for identifying unrecognised organic disease at school entry. The shorter the stature the greater the prevalence of organic disease. The frequency of newly diagnosed remediable disease in this study (1 in 3-4000) is similar to that of neonatal hypothyroidism, which is routinely screened for. Routine investigation of all very short school entrants is recommended.

Entities:  

Mesh:

Year:  1992        PMID: 1486305      PMCID: PMC1883947          DOI: 10.1136/bmj.305.6866.1400

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


  10 in total

Review 1.  Tests for growth hormone secretion.

Authors:  C G Brook; P C Hindmarsh
Journal:  Arch Dis Child       Date:  1991-01       Impact factor: 3.791

Review 2.  Auxological and biochemical assessment of short stature.

Authors:  P C Hindmarsh; C G Brook
Journal:  Acta Paediatr Scand Suppl       Date:  1988

3.  The five year school medical--time for change.

Authors:  G C Smith; A Powell; K Reynolds; C A Campbell
Journal:  Arch Dis Child       Date:  1990-02       Impact factor: 3.791

4.  Causes of short stature. A community study of children in Newcastle upon Tyne.

Authors:  K A Lacey; J M Parkin
Journal:  Lancet       Date:  1974-01-12       Impact factor: 79.321

5.  Health screening in schools. Part II.

Authors:  A W Cross
Journal:  J Pediatr       Date:  1985-11       Impact factor: 4.406

6.  Method for the earlier recognition of abnormal stature.

Authors:  A A Green; J A MacFarlane
Journal:  Arch Dis Child       Date:  1983-07       Impact factor: 3.791

7.  Standards from birth to maturity for height, weight, height velocity, and weight velocity: British children, 1965. I.

Authors:  J M Tanner; R H Whitehouse; M Takaishi
Journal:  Arch Dis Child       Date:  1966-10       Impact factor: 3.791

8.  The reliability of height measurement (the Wessex Growth Study).

Authors:  L D Voss; B J Bailey; K Cumming; T J Wilkin; P R Betts
Journal:  Arch Dis Child       Date:  1990-12       Impact factor: 3.791

9.  Need for new reference curves for height.

Authors:  S Chinn; C E Price; R J Rona
Journal:  Arch Dis Child       Date:  1989-11       Impact factor: 3.791

10.  Differences in physical characteristics, perinatal histories, and social backgrounds between children with growth hormone deficiency and constitutional short stature.

Authors:  G V Vimpani; A F Vimpani; S J Pocock; J W Farquhar
Journal:  Arch Dis Child       Date:  1981-12       Impact factor: 3.791

  10 in total
  29 in total

1.  Growth monitoring.

Authors:  D M Hall
Journal:  Arch Dis Child       Date:  2000-01       Impact factor: 3.791

Review 2.  Management of short stature.

Authors:  Shayne P Taback; Heather J Dean; Elizabeth Elliott
Journal:  West J Med       Date:  2002-05

3.  A search for the evidence supporting community paediatric practice.

Authors:  M C Rudolf; N Lyth; A Bundle; G Rowland; A Kelly; S Bosson; M Garner; P Guest; M Khan; R Thazin; T Bennett; D Damman; V Cove; V Kaur
Journal:  Arch Dis Child       Date:  1999-03       Impact factor: 3.791

4.  The strengths and limitations of parental heights as a predictor of attained height.

Authors:  C M Wright; T D Cheetham
Journal:  Arch Dis Child       Date:  1999-09       Impact factor: 3.791

5.  Changing practice in growth monitoring.

Authors:  L D Voss
Journal:  BMJ       Date:  1999-02-06

Review 6.  Approach to short stature.

Authors:  Sangeeta Yadav; Aashima Dabas
Journal:  Indian J Pediatr       Date:  2014-12-04       Impact factor: 1.967

Review 7.  Genetic evaluation of short stature.

Authors:  Andrew Dauber; Ron G Rosenfeld; Joel N Hirschhorn
Journal:  J Clin Endocrinol Metab       Date:  2014-06-10       Impact factor: 5.958

8.  Low incidence of pathology detection and high cost of screening in the evaluation of asymptomatic short children.

Authors:  Stephanie Sisley; Marcela Vargas Trujillo; Jane Khoury; Philippe Backeljauw
Journal:  J Pediatr       Date:  2013-05-21       Impact factor: 4.406

9.  Adult outcome of normal children who are short or underweight at age 7 years.

Authors:  L Greco; C Power; C Peckham
Journal:  BMJ       Date:  1995-03-18

10.  Growth monitoring: testing the new guidelines.

Authors:  J Mulligan; L D Voss; E S McCaughey; B J Bailey; P R Betts
Journal:  Arch Dis Child       Date:  1998-10       Impact factor: 3.791

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.